Literature DB >> 14978658

The perspective of the patient.

Nancy J Norton1.   

Abstract

The International Foundation for Functional Gastrointestinal Disorders (IFFGD) is a nonprofit education and research group. Founded in 1991, the IFFGD provides information and advice to patients around the world with fecal incontinence and other gastrointestinal disorders, educates physicians through medical symposia and other activities, funds and undertakes research, and provides testimony to Congress about the necessity of furthering research activities related to fecal incontinence through the National Institutes of Health. The IFFGD advocates research directed toward more comprehensive identification of quality-of-life issues associated with fecal incontinence and improved assessment and communication of treatment outcomes related to quality of life, standardization of scales to measure incontinence severity and quality of life, assessment of the utility of diagnostic tests for affecting management strategies and treatment outcomes, development of new drug compounds offering new treatment approaches to fecal incontinence, development and testing of strategies for primary prevention of fecal incontinence associated with childbirth, and further understanding of the process of stigmatization as it applies to the experience of individuals with fecal incontinence.

Entities:  

Mesh:

Year:  2004        PMID: 14978658     DOI: 10.1053/j.gastro.2003.10.081

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  23 in total

Review 1.  Role of diet in fecal incontinence: a systematic review of the literature.

Authors:  Kristen Colavita; Uduak U Andy
Journal:  Int Urogynecol J       Date:  2016-02-16       Impact factor: 2.894

2.  Reasons for non-disclosure of faecal incontinence: a comparison between two survey methods.

Authors:  L Bartlett; M Nowak; Y H Ho
Journal:  Tech Coloproctol       Date:  2007-08-03       Impact factor: 3.781

3.  Continence specialists use of quality of life information in routine practice: a national survey of practitioners.

Authors:  Kirstie L Haywood; Andrew M Garratt; Sandra Carrivick; Joanne Mangnall; Suzanne M Skevington
Journal:  Qual Life Res       Date:  2009-03-07       Impact factor: 4.147

Review 4.  High-Resolution Anorectal Manometry - New Insights in the Diagnostic Assessment of Functional Anorectal Disorders.

Authors:  Henriette Heinrich; Benjamin Misselwitz
Journal:  Visc Med       Date:  2018-04-20

5.  Theoretical tools to analyze anorectal mechanophysiological data generated by the Fecobionics device.

Authors:  Donghua Liao; Abbey Sc Chen; Kar Man Lo; Jingbo Zhao; Kaori Futaba; Hans Gregersen
Journal:  J Biomech Eng       Date:  2019-06-26       Impact factor: 2.097

6.  Incontinence: an underappreciated problem in obesity and bariatric surgery.

Authors:  Adil E Bharucha
Journal:  Dig Dis Sci       Date:  2010-09       Impact factor: 3.199

7.  Factors that affect consultation and screening for fecal incontinence.

Authors:  Lalitha Kunduru; Sung Min Kim; Steve Heymen; William E Whitehead
Journal:  Clin Gastroenterol Hepatol       Date:  2014-08-19       Impact factor: 11.382

8.  Improving biofeedback for the treatment of fecal incontinence in women: implementation of a standardized multi-site manometric biofeedback protocol.

Authors:  A D Markland; J E Jelovsek; W E Whitehead; D K Newman; U U Andy; K Dyer; I Harm-Ernandes; S Cichowski; J McCormick; C Rardin; G Sutkin; A Shaffer; S Meikle
Journal:  Neurogastroenterol Motil       Date:  2016-07-24       Impact factor: 3.598

9.  EuroQol EQ-5D and condition-specific measures of health outcome in women with urinary incontinence: reliability, validity and responsiveness.

Authors:  Kirstie L Haywood; Andrew M Garratt; Ranjit Lall; Jan Fereday Smith; Sarah E Lamb
Journal:  Qual Life Res       Date:  2008-02-15       Impact factor: 4.147

10.  Characterization of symptom severity and impact on four fecal incontinence phenotypes in women presenting for evaluation.

Authors:  Tanya P Hoke; Isuzu Meyer; Christina T Blanchard; Jeff M Szychowski; Holly E Richter
Journal:  Neurourol Urodyn       Date:  2020-10-20       Impact factor: 2.696

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.